BBI LONG ENTRY

Looks like were in a great area to take a starter for Brickell Biotech. Oversold territory with signs of the start of another cup and handle formation. Same one that sent us out of the 1.10's to the high 1.6's. Taking a starter here and will average down as necessary till we take off.

THE PRODUCT: Hyperhidrosis (super sweaty syndrome) gel development and so far trial results are looking great! This condition affects so many people and the market is huge for a product like this!

SHORT TERM PT: 1.83
LONG TERM PT: 5+
Trend Analysis

يعمل أيضًا:

إخلاء المسؤولية